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Abstract
Objective: Strongyloides stercoralis is a soil-transmitted intestinal nematode that has been estimated to infect at
least 60 million people, especially in tropical and subtropical regions. Strongyloides infection has been described in
immunosupressed patients with lymphoma, rheumatoid arthritis, diabetes mellitus etc. Our case who has
rheumatoid arthritis (RA) and bronchial asthma was treated with low dose steroids and methotrexate.
Methods: A 68 year old woman has bronchial asthma for 55 years and also diagnosed RA 7 years ago. She
received immunusupressive agents including methotrexate and steroids. On admission at hospital, she was on
deflazacort 5 mg/day and methotrexate 15 mg/week. On her physical examination, she was afebrile, had rhonchi
and mild epigastric tenderness. She had joint deformities at metacarpophalengeal joints and phalanges but no
active arthritis finding.
Results: Oesophagogastroduodenoscopy was performed and it showed hemorrhagic focus at bulbus. Gastric
biopsy obtained and showed evidence of S.Stercoralis infection. Stool and sputum parasitological examinations
were also all positive for S.stercoralis larvae. Chest radiography result had no pathologic finding. Albendazole 400
mg/day was started for 23 days. After the ivermectin was retrieved, patient was treated with oral ivermectin 200 μg
once a day for 3 days. On her outpatient control at 15th day, stool and sputum samples were all negative for
parasites.
Conclusion: S.stercoralis may cause mortal diseases in patients. Immunosupression frequently causes disseminated
infections. Many infected patients are completely asymptomatic. Although it is important to detect latent S.
stercoralis infections before administering chemotherapy or before the onset of immunosuppression in patients at
risk, a specific and sensitive diagnostic test is lacking. In immunosupressed patients, to detect S.stercoralis might
help to have the patient survived and constitute the exact therapy.
Introduction
Strongyloides stercoralis infects 30 - 100 million people
in 70 countries in tropical and subtropical areas [1-3].
Infection usually results in asymptomatic chronic disease
of the gut, which can remain undetected for decades.
However, in patients receiving long-term corticosteroid
therapy, hyperinfection can occur, resulting in high mor-
tality rates (up to 87%)[1].
Strongyloides stercoralis is an intestinal nematode
parasite. It has the ability to reproduce itself in human.
Humans become infected by filariform larvae [2,4,5]. It
is transmitted from the soil and penetrates into the skin.
After exposure, it can migrate to the respiratory system
via bloodstream. The parasite is, then, swallowed and
entered the gastrointestinal tract. It penetrates the duo-
denum wall. The female leave eggs to small bowel
mucosa. Rhabditiform larvae hatch from the eggs and
expelled in feces; and then, asexual cycle developed in
soil. Rhabditiform larvae turn into males and females,
pass eggs to the soil; filariform larvae are developed and
infected human. A short cycle also takes place in human
body. Rhabditiform larvae mature and penetrate the skin
in perianal area and autoinfection developed [6].
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nonspecific abdominal symptoms with or without mild
sporadic diarrhea. Many infected patients are completely
asymptomatic [3]. The penetration of the colon or the
anal skin by filariform larvae, and its migration through
lung allow reinfection of the same host.
Acute infection can lead a dermatologic sign at the
larval penetration region of the skin[2]. Pulmonary
symptoms including dyspnea, cough, rhonchi, wheezing
occur afterwards. When the parasites are swallowed,
gastrointestinal (GI) symptoms develop before the stool
samples are positive for larvae. Gastrointestinal and pul-
monary symptoms are non-specific and include abdom-
inal pain, diarrhea, vomiting, adynamic ileus, small
bowel obstruction and protein-losing enteropathy, pneu-
monia [2].
Strongyloidiasis is difficult to diagnose because the
parasite load is low and the larval output is irregular.
Results of a single stool examination by use of conven-
tional techniques fail to detect larvae in up to 70% of
the cases [1].
Autoinfection is the major characteristic that seperate S.
stercoralis from the other parasite forms. S.stercoralis may
remain dormant in human body for years. Immunosupres-
sion can trigger replication and cause fatal diseases.
Strongyloides infection has been described in immu-
nosupressed patients with lymphoma, rheumatoid
arthritis, diabetes mellitus etc.
Here we present a case with RA and bronchial
asthma who was treated with low dose steroids and
methotrexate.
Case Report
A 68 years old woman was admitted to hospital with
weakness, dyspepsia and cough in Samsun, Turkey. Her
previous medical history was indicating that she has had
bronchial asthma for 55 years and received short inter-
val prednisolone therapy for exacerbations. She had also
diagnosed RA 7 years ago and received immunusupres-
sive agents including methotrexate and steroids at differ-
ent doses for disease control. On admission to the
hospital, she was on deflazacort 5 mg/day and metho-
trexate 15 mg/week. She had also recurrent inpatient
clinic follow-up history because of resistant hyponatre-
mia with unknown origin and moderate anemia. On her
physical examination, she was afebrile, had rhonchi and
mild epigastric tenderness. She had continuous nausea
and she was sometimes vomiting. She had joint deformi-
ties at metacarpophalengeal joints and phalanges; but no
active arthritis finding. Laboratory data revealed normo-
chrom normocytic anemia, mild hyponatremia (Na:128
mEq). Abdomen and chest radiography were normal.
Kazuto K at all. studied in endoscopic and histopatho-
logical hyperinfection of Strongyloides stercoralis on the
duodenum. Twenty-four (96%) of the patients, investi-
gated were under immunocompromised condition. The
abnormal endoscopic findings, mainly edematous
mucosa, white villi and erythematous mucosa were
observed in 23 (92%) patients. The degree of duodenitis
including villous atrophy/destruction and inflammatory
cell infiltration corresponded to the severity of the endo-
scopic findings. The histopathologic yield for identifying
larvae was 71.4% by duodenal biopsy. The endoscopic
findings of duodenitis were more severe in patients
whose biopsies were positive for larvae than those
whose biopsies were negative [2]. Those patients gastro-
intestinal and pulmonary symptoms are common but
non-specific, and include abdominal pain, diarrhea,
vomiting, adynamic ileus, small bowel obstruction (SBO)
and protein-losing enteropathy, as well as pneumonia [2].
In our patient, oesophagogastroduodenoscopy per-
formed and showed hemorrhagic focus at bulbus (Figure
1). Gastric biopsy obtained and showed evidence of S.
Stercoralis infection (Figures 2 and 3). Microscopically,
chronic gastritis and scattered eosinophils were
observed. Also, histological examination showed numer-
ous larvae in gastric glands and duodenal crypts.
Stool and sputum parasitological examination were
taken. They were also all positive for S.stercoralis larvae.
The samples’ microscopic features are shown at Figures
4 and 5, respectively.
Chest radiography had no pathologic finding. Blood
microscopic examination was negative for larvae. HIV
test was negative. Albendazole 400 mg/day was started.
The steroid therapy ceased by decreasing the dose. At
the 6th day of therapy, sputum and stool samples were
negative for alive S.stercoralis larvae. The therapy
stopped at 15th day.
Figure 1 Hemorrhagic focus at bulbus Gastroduodenoscopic
view.
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became positive again for larvae. Ivermectin planned;
but, as it was not found in our country, albendazole
therapy continued till the drug was provided. At the 23
th day of albendazole, stool and sputum were negative.
After the ivermectin obtained, patient was treated with
oral ivermectin 200 μg once daily for 3 days. On her
outpatient control at 15th day, stool and sputum sam-
ples were all negative for parasite.
Discussion and Review of Literature
Strongyloides stercoralis is an intestinal nematode that is
widely distributed throughout the tropics and subtropics
[1]. Definitive diagnosis of strongyloidiasis usually
depends on the demonstration of S. Stercoralis larvae in
the feces or duodenal fluid. However, in a majority of
uncomplicated cases, the intestinal worm load is low
and the larval output is minimal. A single stool exami-
nation thus fails to detect larvae in up to 70% of cases
[4]. Strongyloides stercoralis is a unique parasite that can
cause a mortal disease years after the exposure. Lam et
al. [7] carried out a retrospective study and searched
seven patients characteristic features. All the patients
left the endemic area more than 20 years ago.
When immunosupression develops, autoinfection
accelerates and hyperinfection occurs. Hyperinfection
has been associated with large numbers of parasites.
T h el a r v a ed on o ts p r e a do u ti nt h en o r m a lm i g r a t i o n
pattern but restricted to GI tract and lungs, whereas dis-
seminated infection results in spreading to any organ.
Multiple organs are affected including lungs, liver, heart,
kidneys and central nervous system. Major complaints
were fever, abdominal pain, diarrhoea, abdominal disten-
sion, weight loss, vomiting, cough, anemia, hemoptysis
[7-11].
Figure 2 Strongyloides larvae are shown in gastric gland and
duodenal crypts.
Figure 3 Strongyloides larvae are shown in gastric gland and
duodenal crypts.
Figure 4 Direct microscopic examination of sputum.
Figure 5 Lugol strained gaita sample, the parasite larvae
feature.
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promise, this autoinfective cycle can become amplified
into a potentially fatal hyperinfection syndrome, charac-
terized by increased numbers of infective filariform lar-
vae in stool and sputum and clinical manifestations of
the increased parasite burden and migration, such as
gastrointestinal bleeding and respiratory distress. S. ster-
coralis hyperinfection is often accompanied by sepsis or
meningitis with enteric organisms. Glucocorticoid treat-
ment and human T-lymphotropic virus type 1 infection
are the two conditions most specifically associated with
triggering hyperinfection, but cases have been reported
in association with hematologic malignancy, malnutri-
tion, and AIDS [5].
In most cases, in the literature, primary complaints were
occasionally evaluated as different diagnosis than strongy-
loides; but, after that duodenal biopsy, bronchoalveolar
lavage, stool and sputum samples showed the parasite.
In the literature, there were cases with marked gastro-
intestinal symptoms [7-10]. Lam et al. [7] stated that 4
of their 7 patients had intestinal ileus clinic with vomit-
ing whom required nazogastric decompression. Das
et al. [8] presented a farmer with seropositive RA with
chronic diarrhea. Krishnamurthy et al. [9] also reported
aR Ac a s ew i t hv o m i t i n ga n da b d o m i n a ld i s c o m f o r t .
Culha et al. [10] marked a case with diarrhea which dif-
fers from the other studies as the patient had no immu-
nosupressive status. Diarrhea and abdominal distension
were not present at our patient, and also she had consti-
pation story. Segarra-Newnham [11] reviewed the litera-
ture for S.stercoralis cases and over 50 of these cases
hyperinfection and disseminated infection were found.
In this study, the most common risk factor was found
to be the steroid usage (64%). Our patient also has been
on low dose steroid therapy.
In our case, the patient’s gastrointestinal complaint was
dyspepsia and vomiting. She had complaints about cough-
ing and shortness of breath; but, expressed that it was pre-
sent till her asthma was developed. We first evaluated her
respiratory symptoms to her primary disease and did not
think of a parasitic disease till we took the pathology result.
After S.stercoralis identified in duodenal biopsy samples,
we took recurrent stool and sputum samples, and all were
positive for the parasite. After that, albendazole therapy
was started. When we started the therapy, the patient’s
hyponatremia and mild anemia was improved firstly.
Conclusion
S.stercoralis can cause mortal diseases in patients. The
parasite is unique among the parasitic nematodes
because of its ability to multiply within the human host
even after many decades, with the potential to cause life-
threatening disease in immunocompromised patients.
Immunosupression frequently cause disseminated
infection and the disease control rates unfortunately are
not in the desirable ratio. In immunosupressed patients,
to evaluate S.stercoralis infection might help for the sur-
vival of the patient and constitute the exact therapy.
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